In humans, exercise supports brain health, reducing the risk of neurodegenerative and psychiatric disorders.
credit: iStock/AscentXmedia
Exercise
may be a goldmine for drug discovery: hormones, peptides, and other
proteins produced in the body during physical activity could prove to be
valuable therapeutics for treating many neurodegenerative or
psychiatric disorders. But scientists are only beginning to understand
the many mechanisms by which exercise benefits the brain. Some of the
benefits likely come from physiological changes that happen during and
after exercise; for example, blood flow to many areas of the brain,
including the hippocampus, increases (2). Cerebrospinal fluid movement
through the brain’s glymphatic system, through which the brain disposes
of waste products including amyloid beta, also increases (3). Benefits
likely also stem from exercise-induced synaptic plasticity (the ability
of neurons to alter their connections with each other) or neurogenesis
(the creation of new neurons).
While exercise-induced
neuroprotection is beginning to be understood at the cellular level,
much less is known about the molecular mechanisms. Elucidating molecular
mechanisms is crucial if scientists want to develop therapies that
mimic the brain benefits of exercise; it’s all very well to say that
exercise exerts these effects through neurogenesis, but scientists can’t
put neurogenesis in a pill.
Back to the beginning In
1982, Swiss neurobiologists discovered a protein in pig brains that
boosted neuron survival. They named it brain-derived neurotrophic growth
factor, or BDNF (4). BDNF is crucial for neurogenesis and
neuroplasticity and is one of the most extensively studied links between
exercise and brain health. While many scientists initially had high
hopes for BDNF as a therapeutic, clinical trials testing it for treating
neurodegenerative disorders have not yet succeeded, possibly due to
difficulties with delivering enough of the protein to the appropriate
parts of the brain (5).
Fortunately, researchers like Tara Walker,
a neuroscientist at the Queensland Brain Institute, are hard at work
identifying other signaling molecules that link exercise and brain
health. Walker is an avid runner herself, and has recently completed her
first trail ultramarathon. Her love of running plays a major role in
her work as well as in her personal life. “My running impacted my
research rather than the other way around,” she said. “I became
fascinated with trying to understand how exercise positively affects the
brain.”
She knew that neurogenesis likely linked the two.
“Exercise is one of the strongest physiological ways that we can
increase adult neurogenesis,” she said. And while BDNF is important in
this process, there is more to the story.
Exercise is one of the strongest physiological ways that we can increase adult neurogenesis. – Tara Walker, Queensland Brain Institute
Walker
hypothesized that the benefits of exercise might originate not in the
brain, but outside it. “Exercise is a full body action, so we figured
that there must be something released into the blood that is somehow
mediating this response,” she said.
She’s not the only one to have
this hunch: two other researchers have since demonstrated that
transferring plasma from mice that have exercised to sedentary mice
transferred some of the benefits of exercise, including increased
neurogenesis, improved cognition, and reduced neuroinflammation (6,7).
Other researchers are currently attempting to treat patients with early
stage Alzheimer’s disease using plasma donated by people who exercise
regularly (8).
In order to identify these beneficial bloodborne
factors, Walker and her team compared the plasma from running mice to
that of sedentary mice. They found significant differences in the
amounts of dozens of proteins between the two groups (9). Since several
of the proteins elevated by running were related to platelets, Walker
decided to investigate these tiny blood cell fragments further.
Walker
found that exercise increased a cytokine produced by platelets, called
platelet factor 4 or PF4. In mice, PF4 didn’t seem to increase neuronal
proliferation when Walker’s team infused it into the hippocampus, but it
did increase the survival of immature neurons, which is an important
part of the process of neurogenesis (9).
While scientists have
studied PF4 in the context of blood coagulation and immune function,
“there’s not really much else known about PF4 in the brain, so it’s
uncharted territory,” said Walker. “That’s why we’re really interested
in it.” She is currently studying the effects of PF4 on the brain in the
context of aging.
Exercise also boosts another protein:
selenoprotein P, a selenium transport protein that is critical for
transporting selenium from blood to the brain (10). When the researchers
deleted this protein, mice no longer experienced exercise induced
neurogenesis. Further studies showed that dietary selenium boosted
neurogenesis in aging mice and protected cognitive abilities after an
injury to the hippocampus.
Walker cautioned that selenium has a
narrow therapeutic range. While tiny amounts of selenium are essential,
the recommended daily allowance for humans is only 55 micrograms,
approximately 1000 times smaller than the mass of one grain of rice;
higher doses can be toxic (11). Instead of long-term selenium
supplementation, she thinks that short-term treatment after brain
injuries will likely be the most promising application, an idea that she
continues to explore.
Learning how muscles talk While
Walker is a neuroscientist who took an interest in exercise, Bruce
Spiegelman, a cell biologist at Harvard Medical School, studied energy
metabolism in fat and muscle cells for years before he became interested
in the brain.
Although he didn’t realize it at the time, this
journey began decades ago with his discovery of PGC-1α, an important
protein for energy metabolism, in 1998 (12). Exercise increases PGC-1α
in muscle tissue, but the protein also appears to mediate many of the
downstream effects of exercise (13).
“In 2002, we put [PGC-1α] in
muscle and we discovered that it gave muscle many of the attributes of
muscle that had been exercised,” said Spiegelman. “It occurred to us
that maybe this work could be extended. It was known that muscle talks
to other tissues… And so, the question is if we dropped PGC-1α into
muscle cells in culture or into muscle tissue in vivo , could we
make a simplified system that would allow us to discover factors
secreted by muscle that may carry some of the benefits of exercise?”
Spiegelman’s
team found that PGC-1α expression in muscle tissue caused the muscle
cells to secrete a previously undiscovered hormone that they named
irisin; follow-up studies showed that mice and humans produced irisin
during exercise as well (14). Spiegelman’s team next determined to find
out if muscles used irisin to “talk” to other tissues, and if so, what
message they sent.
As one of her first projects as a postdoctoral
researcher in Spiegelman’s lab, Christiane Wrann, who is now an exercise
and metabolism researcher at Massachusetts General Hospital, measured
irisin in different tissues in the body. “It's not just very high in
skeletal muscle; it's also very high in the brain, in the hippocampus,”
she said.
This got her thinking. “We do know irisin is an exercise
hormone and we do know exercise is good for the brain. Is it possible
that irisin is one of these important connectors — how exercise is
improving brain function?” Together with her team, Wrann showed that in
mice, boosting irisin in the blood increased BDNF gene expression in the hippocampus, suggesting potential brain benefits (15).
Wrann
continues to study the effects of exercise on the brain. She recently
discovered that increasing irisin in the body improves cognition and
reduces neuroinflammation in a mouse model of Alzheimer’s disease (16).
Exercise inspired drugs effectively reduce symptoms in mouse models of some neurodegenerative disorders.
credit: istock/JamesBrey
Since
neuroinflammation is involved in many types of brain dysfunction, Wrann
is excited about the potential to investigate irisin for Alzheimer’s
disease and other neurodegenerative diseases.
In the context of
Parkinson’s disease, Spiegelman’s team found that irisin reduces
α-synuclein accumulation in mice, resulting in increased dopaminergic
neuron survival (17).
There are still some hurdles to overcome
before irisin makes it to the clinic. One snag may be its relatively
short half-life in blood (18). While researchers have tested using viral
vectors to elevate irisin expression in mice long term, gene therapy
for humans is still in its infancy, so the pharmacokinetics of irisin
will likely need to be assessed prior to human use. According to
Spiegelman, pharmacokinetic profiles of irisin within the brain may be
different than in the blood; they are currently examining this.
Depending on the results of those tests, scientists may need to modify
the protein to produce a longer half-life without abolishing the
therapeutic value.
Other next steps for irisin research include
expanding into nonhuman primate models of neurodegenerative diseases as
well as examining the efficacy of irisin in mouse models of other
diseases, such as depression.
Many Threads to Untangle A
handful of other proteins, including adiponectin, cathepsin B,
clusterin, Gpld1, and lactate also mediate the effects of exercise on
the brain. Even more may be awaiting discovery (6,7,19–21).
“I
think that the reason exercise is so beneficial is that there isn't a
single molecular pathway that's not affected,” said Erickson. “We know
that exercise is affecting thousands of different pathways and every
organ system in the body.”
Even with further discovery, it is
unlikely that a single molecule will ever mimic all of the benefits of
exercise; scientists developing drugs to mimic the effects of exercise
don’t intend them to replace regular exercise throughout a person’s
lifetime, but rather to be used in specific circumstances.
“Our
long-term goal is to understand how exercise increases neurogenesis and
try to develop novel ways to mimic that exercise induced neurogenesis
for people who can’t exercise,” said Walker. “Obviously you can’t tell
someone who’s just had a stroke or who has Alzheimer’s to go out and run
a marathon.”
While there’s still a lot to learn, researchers hope
that by unraveling the secrets of exercise, they will one day provide
desperately needed therapeutics for devastating neurodegenerative and
psychiatric conditions.
References at link.
No comments:
Post a Comment